Pichavant C - Search Results

1

Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles.

Pichavant C, Chapdelaine P, Cerri DG, Bizario JC, Tremblay JP. Pichavant C, et al. Hum Gene Ther. 2010 Nov;21(11):1591-601. doi: 10.1089/hum.2010.024. Hum Gene Ther. 2010. PMID: 20553115

2

Meganucleases can restore the reading frame of a mutated dystrophin.

Chapdelaine P, Pichavant C, Rousseau J, Pâques F, Tremblay JP. Chapdelaine P, et al. Among authors: pichavant c. Gene Ther. 2010 Jul;17(7):846-58. doi: 10.1038/gt.2010.26. Epub 2010 Apr 15. Gene Ther. 2010. PMID: 20393509

3

Expression of dog microdystrophin in mouse and dog muscles by gene therapy.

Pichavant C, Chapdelaine P, Cerri DG, Dominique JC, Quenneville SP, Skuk D, Kornegay JN, Bizario JC, Xiao X, Tremblay JP. Pichavant C, et al. Mol Ther. 2010 May;18(5):1002-9. doi: 10.1038/mt.2010.23. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179674 Free PMC article.

4

Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.

Stephan L, Pichavant C, Bouchentouf M, Mills P, Camirand G, Tagmouti S, Rothstein D, Tremblay JP. Stephan L, et al. Among authors: pichavant c. Cell Transplant. 2006;15(8-9):835-46. doi: 10.3727/000000006783981521. Cell Transplant. 2006. PMID: 17269453 Free article.

5

Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. Pichavant C, et al. Mol Ther. 2011 May;19(5):830-40. doi: 10.1038/mt.2011.59. Epub 2011 Apr 5. Mol Ther. 2011. PMID: 21468001 Free PMC article. Review.

6

Generation of lentiviral vectors for use in skeletal muscle research.

Pichavant C, Tremblay JP. Pichavant C, et al. Methods Mol Biol. 2012;798:285-95. doi: 10.1007/978-1-61779-343-1_16. Methods Mol Biol. 2012. PMID: 22130843

7

Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success.

Pichavant C, Gargioli C, Tremblay JP. Pichavant C, et al. PLoS Curr. 2011 Oct 26;3:RRN1275. doi: 10.1371/currents.RRN1275. PLoS Curr. 2011. PMID: 22052037 Free PMC article.

8

Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress.

Pichavant C, Burkholder TJ, Pavlath GK. Pichavant C, et al. Skelet Muscle. 2016 Jan 21;6:2. doi: 10.1186/s13395-016-0077-7. eCollection 2016. Skelet Muscle. 2016. PMID: 26798450 Free PMC article.

9

Creatine kinase B is necessary to limit myoblast fusion during myogenesis.

Simionescu-Bankston A, Pichavant C, Canner JP, Apponi LH, Wang Y, Steeds C, Olthoff JT, Belanto JJ, Ervasti JM, Pavlath GK. Simionescu-Bankston A, et al. Among authors: pichavant c. Am J Physiol Cell Physiol. 2015 Jun 1;308(11):C919-31. doi: 10.1152/ajpcell.00029.2015. Epub 2015 Mar 25. Am J Physiol Cell Physiol. 2015. PMID: 25810257 Free PMC article.

10

Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy.

Guha TK, Pichavant C, Calos MP. Guha TK, et al. Among authors: pichavant c. Mol Ther Methods Clin Dev. 2019 Oct 14;15:294-304. doi: 10.1016/j.omtm.2019.10.002. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31890729 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page